However, little is known about the role of EP3 receptors in the vascular remodeling of CSVD induced by hypertension, and whether downregulation or blockade of EP3 will improve the functional outcomes of CSVD is still unknown. The gene discussed is PTGER3; the disease is hypertensive disorder.